Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
administration of a shot of Shingrix with an unapproved diluent; administration of a shot of Shingrix with an unapproved diluent; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 10-OCT-2025, the patient received Shingrix. On 10-OCT-2025, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: administration of a shot of Shingrix with an unapproved diluent) and inappropriate dose of vaccine administered (Verbatim: administration of a shot of Shingrix with an unapproved diluent). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 13-OCT-2025 A registered pharmacist called to report the administration of a shot of Shingrix with an unapproved diluent (non-specified from the reporter's end). The batch number was not provided upon follow-up with the reporter. No vaccine detail was obtained in this call. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.